NCT06688955 Microbiological and Organizational Impact of the Use of Bacteriologically Controlled Water in COLOscopy
| NCT ID | NCT06688955 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Bordeaux |
| Condition | Colonoscopy |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2025-09-29 |
| Primary Completion | 2025-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2025-09-29 with a primary completion date of 2025-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
A joint opinion of the SFED and the SF2H recommends to orient our colonoscopy practices towards the use of bacteriologically controlled water in reusable bottles for colonic irrigation. To date, no study exists to validate the proposed set-up. Our main objective is therefore to evaluate the microbiological safety of the use of bacteriologically controlled water, in particular the absence of retro contamination of the water in the wash bottle by the faecal flora of the patient undergoing colonoscopy, in order to be able to generalise this practice
Eligibility Criteria
Inclusion Criteria: * All patients with a colonoscopy indication whose examination is scheduled in room 4, on a Monday and Tuesday shift (8:30 a.m. - 1:30 p.m.) * Male or female of legal age at the time the colonoscopy is ordered * Patient willing to participate in the study * Person affiliated with or benefiting from a social security plan Exclusion Criteria: * Pregnant woman * Patient of legal age under guardianship or protected person * Patient requiring indigo-carmine chromoendoscopy * Patient requiring an emergency colonoscopy * Patient not affiliated to the social security system
Contact & Investigator
Arthur BERGER
PRINCIPAL INVESTIGATOR
University Hospital, Bordeaux
Frequently Asked Questions
Who can join the NCT06688955 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Colonoscopy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06688955 currently recruiting?
Yes, NCT06688955 is actively recruiting participants. Contact the research team at arthur.berger@chu-bordeaux.fr for enrollment information.
Where is the NCT06688955 trial being conducted?
This trial is being conducted at Pessac, France.
Who is sponsoring the NCT06688955 clinical trial?
NCT06688955 is sponsored by University Hospital, Bordeaux. The principal investigator is Arthur BERGER at University Hospital, Bordeaux. The trial plans to enroll 40 participants.